Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
uracil + alpha-D-ribose 1-phosphate
uridine + phosphate
-
-
-
r
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
2'-deoxyuridine + phosphate
uracil + deoxyribose 1-phosphate
-
-
-
-
?
5'-deoxy-5-fluorouridine + alpha-D-ribose 1-phosphate
5'-deoxy-5-fluorouridine + phosphate
-
-
-
-
?
5-fluoro-2'-deoxyuridine + phosphate
5-fluorouracil + 2-deoxy-alpha-D-ribose 1-phosphate
-
-
-
?
5-fluoro-2'-deoxyuridine + phosphate
5-fluorouracil + 2-deoxy-D-ribose-1-phosphate
-
-
also accepts 2'-deoxypyrimidine nucleosides in higher organisms
-
r
5-fluorouracil + alpha-D-ribose 1-phosphate
5-fluorouridine + phosphate
-
-
-
-
?
5-fluorouracil + alpha-D-ribose-1-phosphate
5-fluorouridine + phosphate
-
-
-
-
?
5-fluorouridine + phosphate
5-fluorouracil + alpha-D-ribose 1-phosphate
5-fluorouridine + phosphate
5-fluorouracil + alpha-D-ribose-1-phosphate
deoxyuridine + phosphate
uracil + 2-deoxy-alpha-D-ribose 1-phosphate
-
-
-
?
thymidine + phosphate
thymine + 2-deoxy-alpha-D-ribose 1-phosphate
uracil + alpha-D-ribose 1-phosphate
uridine + phosphate
-
-
-
-
?
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
additional information
?
-
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
?
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
r
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
-
r
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
r
5-fluorouridine + phosphate
5-fluorouracil + alpha-D-ribose 1-phosphate
-
-
-
-
?
5-fluorouridine + phosphate
5-fluorouracil + alpha-D-ribose 1-phosphate
-
-
-
-
r
5-fluorouridine + phosphate
5-fluorouracil + alpha-D-ribose-1-phosphate
-
-
-
?
5-fluorouridine + phosphate
5-fluorouracil + alpha-D-ribose-1-phosphate
-
15% of the activity with uridine
-
-
?
thymidine + phosphate
thymine + 2-deoxy-alpha-D-ribose 1-phosphate
-
-
-
-
?
thymidine + phosphate
thymine + 2-deoxy-alpha-D-ribose 1-phosphate
-
-
-
?
thymidine + phosphate
thymine + 2-deoxy-alpha-D-ribose 1-phosphate
-
to a lesser extent compared to uridine
-
-
?
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
-
?
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
r
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
-
r
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
-
-
?
uridine + phosphate
uracil + alpha-D-ribose 1-phosphate
-
liver enzyme is highly specific to uridine
-
-
?
additional information
?
-
UPP catalyzes the reversible phosphorolysis of uracil ribosides and analogous compounds to their respective nucleobases and ribose-1-phosphate, structural mechanisms, overview
-
-
?
additional information
?
-
-
UPP catalyzes the reversible phosphorolysis of uracil ribosides and analogous compounds to their respective nucleobases and ribose-1-phosphate, structural mechanisms, overview
-
-
?
additional information
?
-
-
no substrates are: thymidine, deoxyuridine, fluorodeoxyuridiune, 5'-deoxyfluorouridine
-
-
?
additional information
?
-
-
no substrate: 5-substituted-2,2'-anhydrouridine
-
-
?
additional information
?
-
-
catalyzes the first step of uridine degradation to beta-alanine in liver
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-benzyl-6-hydroxy-2-oxo-1,2-dihydropyridine-3-carbonitrile
2% inhibition at 0.001 mM
4-ethyl-6-hydroxy-2-oxo-1,2-dihydropyridine-3-carbonitrile
25% inhibition at 0.001 mM
4-hydroxy-5-[[(2-hydroxyethyl)amino]methyl]-3,4-dihydropyrimidin-2(1H)-one
2% inhibition at 0.001 mM
5-benzyl-1-(2'-hydroxyethoxymethyl)uracil
competitive inhibition with respect to uridine, noncompetitive inhibition with respect to phosphate
5-benzyl-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
43% inhibition at 0.001 mM
5-[(diethylamino)methyl]-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
25% inhibition at 0.001 mM
5-[(dimethylamino)methyl]-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
81% inhibition at 0.001 mM
5-[[(1,3-dihydroxypropan-2-yl)amino]methyl]-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
82% inhibition at 0.001 mM
5-[[(2,3-dihydroxypropyl)amino]methyl]-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
78% inhibition at 0.001 mM
6-hydroxy-1H-pyridin-2-one
38% inhibition at 0.001 mM
6-hydroxy-2-oxo-1,2-dihydropyridine-3-carbonitrile
67% inhibition at 0.001 mM
6-hydroxy-2-oxo-4-(propan-2-yl)-1,2-dihydropyridine-3-carbonitrile
31% inhibition at 0.001 mM
6-hydroxy-2-oxo-4-phenyl-1,2-dihydropyridine-3-carbonitrile
42% inhibition at 0.001 mM
6-hydroxy-2-oxo-4-propyl-1,2-dihydropyridine-3-carbonitrile
16% inhibition at 0.001 mM
6-hydroxy-3,4-dimethylpyridin-2(1H)-one
9.5% inhibition at 0.001 mM
6-hydroxy-3-methylpyridin-2(1H)-one
12% inhibition at 0.001 mM
6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
70% inhibition at 0.001 mM
6-hydroxy-4-methyl-2-oxo-5-phenyl-1,2-dihydropyridine-3-carbonitrile
12% inhibition at 0.001 mM
6-hydroxy-4-methyl-2-oxo-5-[(piperidin-1-yl)methyl]-1,2-dihydropyridine-3-carbonitrile
49% inhibition at 0.001 mM
6-hydroxy-4-methyl-5-[(morpholin-4-yl)methyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile
51% inhibition at 0.001 mM
6-hydroxy-4-methylpyridin-2(1H)-one
16% inhibition at 0.001 mM
6-hydroxy-4-propyl-1H-pyridin-2-one-3-carbonitrile
16% inhibition at 0.001 mM
6-hydroxy-5-(((2-hydroxyethyl)amino)methyl)-4-methyl-1H-pyridin-2-one-3-carbonitrile
80% inhibition at 0.001 mM
alpha-D-ribose 1-phosphate
product inhibition pattern, noncompetitive versus uridine, competitive versus phosphate, overview
potassium 5-cyano-4-methyl-6-oxo-1,6-dihydropyridin-2-olate
60% inhibition at 0.001 mM
Uracil
product inhibition pattern, noncompetitive versus uridine and phosphate, overview
2'-deoxyglycosylthymine
-
-
2,2'-Anhydro-5-ethyluridine
-
-
2-deoxyglycosylthymine
-
-
5-(3'-Benzyloxybenzyl)-1-[(1'-aminomethyl-2'-hydroxyethoxy)methyl]uracil
-
-
5-fluoro-2'-deoxyuridine
-
-
5-fluoroacyclouridine
-
-
5-Substituted 2,2'-anhydrouridine
-
-
Acyclothymidine
-
competitive
acyclouridine
-
competitive
Pyrimidine acyclonucleosides
-
competitive
-
5-benzylacyclouridine
an UPP1-specific inhibitor. Binding of the inhibitor to the UPP1 active site, structure, overview
5-benzylacyclouridine
BAU
5-benzylacyclouridine
-
-
5-benzylacyclouridine
-
0.01 mM, 90% inhibition of normal tissues, 40-60% inhibition of carcinoma tissue
Benzylacyclouridines
-
-
-
Benzylacyclouridines
-
0.1 mM
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acidosis
Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs.
Acidosis
Renal tubular acidosis.
Adenocarcinoma
Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
Adenocarcinoma
Purification, cloning, and expression of murine uridine phosphorylase.
Anemia
Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.
Breast Neoplasms
Activation of Stat1, IRF-1, and NF-kappaB is required for the induction of uridine phosphorylase by tumor necrosis factor-alpha and interferon-gamma.
Breast Neoplasms
Expression of uridine and thymidine phosphorylase genes in human breast carcinoma.
Breast Neoplasms
Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase.
Breast Neoplasms
Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells.
Breast Neoplasms
p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
Breast Neoplasms
Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
Breast Neoplasms
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Breast Neoplasms
Uridine phosphorylase in breast cancer: a new prognostic factor?
Bronchial Spasm
[Anaphylactic shock during the use of high doses of aprotinin in cardiac surgery]
Carcinogenesis
Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.
Carcinogenesis
Uridine homeostatic disorder leads to DNA damage and tumorigenesis.
Carcinoma
Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.
Carcinoma
Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
Carcinoma
Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine.
Carcinoma
Specific activities of uridine phosphorylase and uridine kinase in Ehrlich ascites carcinoma cells and 6-azauracil- and 6-azauridine-treated sublines in successive transplant generations.
Carcinoma
Uridine phosphorylase and uridine kinase activities of the Ehrlich ascites carcinoma.
Carcinoma
Uridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinoma.
Carcinoma, Hepatocellular
Uridine homeostatic disorder leads to DNA damage and tumorigenesis.
Carcinoma, Hepatocellular
Uridine phosphorylase from Novikoff rat hepatoma cells: purification, kinetic properties, and its role in uracil anabolism.
Colonic Neoplasms
Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
Colonic Neoplasms
[Analysis of the salvage synthesis within biosynthesis of nucleic acid route in colon cancer]
Colorectal Neoplasms
Cloning and expression of human uridine phosphorylase.
Colorectal Neoplasms
Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.
Colorectal Neoplasms
Real-time RT-PCR (TaqMan) of tumor mRNA to predict sensitivity of specimens to 5-fluorouracil.
Colorectal Neoplasms
Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer.
Communicable Diseases
X-ray structure of Salmonella typhimurium uridine phosphorylase complexed with 5-fluorouracil and molecular modelling of the complex of 5-fluorouracil with uridine phosphorylase from Vibrio cholerae.
Coronary Disease
[Analysis of the misdiagnoses of obliterative pulmonary hypertension]
Diabetes Mellitus, Type 1
A perfect storm: Genetics and anticommensal antibodies shore up type 1 diabetes.
Dyslipidemias
Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
Exanthema
[Anaphylactic shock during the use of high doses of aprotinin in cardiac surgery]
Glioma
Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Head and Neck Neoplasms
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Heart Defects, Congenital
[Analysis of the misdiagnoses of obliterative pulmonary hypertension]
Heart Valve Diseases
[Analysis of the misdiagnoses of obliterative pulmonary hypertension]
Hypertension
Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
Hypocalcemia
Measurement of urine pH and net acid excretion and their association with urine calcium excretion in periparturient dairy cows.
Hypotension
[Anaphylactic shock during the use of high doses of aprotinin in cardiac surgery]
Infections
Structural and catalytic analysis of two diverse uridine phosphorylases in Phytophthora capsici.
Leukemia
Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
Leukemia
[Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues]
Liver Cirrhosis
Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo.
Lung Neoplasms
In vitro simulation study of individualized chemotherapy in lung cancer.
Lymphoma
Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
Lymphoma
Uridine homeostatic disorder leads to DNA damage and tumorigenesis.
Melanoma
High uridine phosphorylase activity in human melanoma tumor.
Metabolic Syndrome
Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
Mucositis
Human uridine phosphorylase-1 inhibitors: a new approach to ameliorate 5-fluorouracil-induced intestinal mucositis.
Myocardial Infarction
Prognostic value of spot testing urine pH as a novel marker in patients with ST-segment elevation myocardial infarction.
Neoplasm Metastasis
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.
Neoplasm Metastasis
Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.
Neoplasm Metastasis
Uridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinoma.
Neoplasms
19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine.
Neoplasms
Activation of Stat1, IRF-1, and NF-kappaB is required for the induction of uridine phosphorylase by tumor necrosis factor-alpha and interferon-gamma.
Neoplasms
Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Neoplasms
Augmentation of antitumor activity of 5'-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo.
Neoplasms
Cloning and expression of human uridine phosphorylase.
Neoplasms
Development of inhibitors of pyrimidine metabolism.
Neoplasms
Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.
Neoplasms
Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
Neoplasms
Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
Neoplasms
Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.
Neoplasms
Expression of uridine and thymidine phosphorylase genes in human breast carcinoma.
Neoplasms
Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.
Neoplasms
Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase.
Neoplasms
High uridine phosphorylase activity in human melanoma tumor.
Neoplasms
Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update.
Neoplasms
In silico/in vitro study of hybrid D-modified steroidal alkylator anticancer activity using uridine phosphorylase as target protein.
Neoplasms
Induction of thymidine phosphorylase by interferon and taxanes occurs only in human cancer cells with low thymidine phosphorylase activity.
Neoplasms
Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
Neoplasms
Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracil.
Neoplasms
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Neoplasms
Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells.
Neoplasms
peroxisome proliferator-activated receptor gamma coactivator-1alpha enhances antiproliferative activity of 5'-deoxy-5-fluorouridine in cancer cells through induction of uridine phosphorylase.
Neoplasms
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.
Neoplasms
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.
Neoplasms
Purification, cloning, and expression of murine uridine phosphorylase.
Neoplasms
Real-time RT-PCR (TaqMan) of tumor mRNA to predict sensitivity of specimens to 5-fluorouracil.
Neoplasms
Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.
Neoplasms
Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
Neoplasms
Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
Neoplasms
Synthesis and biological activity of 5'-substituted 5-fluoropyrimidine nucleosides.
Neoplasms
Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancers.
Neoplasms
The kinetic mechanism of human uridine phosphorylase 1: Towards the development of enzyme inhibitors for cancer chemotherapy.
Neoplasms
The role of interferon-alpha as a modulator of fluorouracil and leucovorin.
Neoplasms
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro.
Neoplasms
Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis.
Neoplasms
Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer.
Neoplasms
Uridine homeostatic disorder leads to DNA damage and tumorigenesis.
Neoplasms
Uridine phosophorylase: an important enzyme in pyrimidine metabolism and fluoropyrimidine activation.
Neoplasms
Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
Neoplasms
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Neoplasms
Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Neoplasms
Uridine phosphorylase in breast cancer: a new prognostic factor?
Neoplasms
Uridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinoma.
Neoplasms
X-ray structure of Salmonella typhimurium uridine phosphorylase complexed with 5-fluorouracil and molecular modelling of the complex of 5-fluorouracil with uridine phosphorylase from Vibrio cholerae.
Neoplasms
[5'-Deoxy-5-fluorouridine enzymatic activation from the masked compound to 5-fluorouracil in human malignant tissues]
Neoplasms
[Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues]
Neoplasms
[Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts]
Neoplasms
[Mode of action of fluoropyrimidines, in relation to their clinical application]
Nephrolithiasis
Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.
Nephrotic Syndrome
High (?6.5) Spontaneous and Persistent Urinary pH Is Protective of Renal Function at Baseline and during Disease Course in Idiopathic Membranous Nephropathy.
Obesity, Abdominal
Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
Pancreatic Neoplasms
In silico/in vitro study of hybrid D-modified steroidal alkylator anticancer activity using uridine phosphorylase as target protein.
Pancreatitis
[Autoimmune pancreatitis: Report of 10 cases]
Prostatic Neoplasms
Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell lines.
Sarcoma 180
Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine.
Sarcoma 180
Synthesis of 1-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]-5-benzyluracil and its amino analogue, new potent uridine phosphorylase inhibitors with high water solubility.
Sleep Apnea Syndromes
Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes.
Squamous Cell Carcinoma of Head and Neck
Uridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinoma.
Thyroid Neoplasms
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
el Kouni, M.H.; el Kouni, M.M.; Naguib, F.N.
Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines
Cancer Res.
53
3687-3693
1993
Homo sapiens, Mus musculus
brenda
Pizzorno, G.; Cao, D.; Leffert, J.J.; Russell, R.L.; Zhang, D.; Handschumacher, R.E.
Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update
Biochim. Biophys. Acta
1587
133-144
2002
Homo sapiens, Mus musculus
brenda
Liu, M.; Cao, D.; Russell, R.; Handschumacher, R.E.; Pizzorno, G.
Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors
Cancer Res.
58
5418-5424
1998
Homo sapiens, Mus musculus
brenda
Niedzwicki, J.G.; El Kouni, M.H.; Chu, S.H.; Cha, S.
Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase
Biochem. Pharmacol.
30
2097-2101
1981
Homo sapiens
brenda
Veres, Z.; Szabolcs, A.; Szinai, I.; Denes, G.; Kajtar-Peredy, M.; Otvos, L.
5-Substituted-2,2-anhydrouridines, potent inhibitors of uridine phosphorylase
Biochem. Pharmacol.
34
1737-1740
1985
Homo sapiens, Mus musculus
brenda
Naguib, F.N.M.; El Kouni, M.H.; Chu, S.H.; Cha, S.
New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers
Biochem. Pharmacol.
36
2195-2201
1987
Homo sapiens, Mus musculus
brenda
Johansson, M.
Identification of a novel human uridine phosphorylase
Biochem. Biophys. Res. Commun.
307
41-46
2003
Mus musculus, Homo sapiens (O95045), Homo sapiens
brenda
Yano, S.; Kazuno, H.; Suzuki, N.; Emura, T.; Wierzba, K.; Yamashita, J.; Tada, Y.; Yamada, Y.; Fukushima, M.; Asao, T.
Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase
Bioorg. Med. Chem.
12
3431-3441
2004
Bos taurus, Equus caballus, Ovis aries, Homo sapiens, Mus musculus, Rattus norvegicus, Sus scrofa
brenda
Yan, R.; Wan, L.; Pizzorno, G.; Cao, D.
Uridine phosphorylase in breast cancer: a new prognostic factor?
Front. Biosci.
11
2759-2766
2006
Gallus gallus, Homo sapiens, Rattus norvegicus
brenda
Temmink, O.H.; de Bruin, M.; Laan, A.C.; Turksma, A.W.; Cricca, S.; Masterson, A.J.; Noordhuis, P.; Peters, G.J.
The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells
Int. J. Biochem. Cell Biol.
38
1759-1765
2006
Homo sapiens
brenda
Temmink, O.H.; de Bruin, M.; Turksma, A.W.; Cricca, S.; Laan, A.C.; Peters, G.J.
Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines
Int. J. Biochem. Cell Biol.
39
565-575
2007
Homo sapiens
brenda
Balestri, F.; Barsotti, C.; Lutzemberger, L.; Camici, M.; Ipata, P.L.
Key role of uridine kinase and uridine phosphorylase in the homeostatic regulation of purine and pyrimidine salvage in brain
Neurochem. Int.
51
517-523
2007
Homo sapiens, Rattus norvegicus
brenda
Kawamura, K.; Takiguchi, N.; Wada, A.; Takenobu, H.; Kimura, H.; Soda, H.; Nagata, M.; Asano, T.; Tagawa, M.
Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis
Anticancer Res.
26
4647-4651
2007
Homo sapiens
brenda
Renck, D.; Ducati, R.G.; Palma, M.S.; Santos, D.S.; Basso, L.A.
The kinetic mechanism of human uridine phosphorylase 1: Towards the development of enzyme inhibitors for cancer chemotherapy
Arch. Biochem. Biophys.
497
35-42
2010
Homo sapiens (Q16831), Homo sapiens
brenda
Roosild, T.P.; Castronovo, S.; Fabbiani, M.; Pizzorno, G.
Implications of the structure of human uridine phosphorylase 1 on the development of novel inhibitors for improving the therapeutic window of fluoropyrimidine chemotherapy
BMC Struct. Biol.
9
14
2009
Homo sapiens (Q16831), Homo sapiens
brenda
Kong, X.; Fan, H.; Liu, X.; Wang, R.; Liang, J.; Gupta, N.; Chen, Y.; Fang, F.; Chang, Y.
Peroxisome proliferator-activated receptor gamma coactivator-1alpha enhances antiproliferative activity of 5-deoxy-5-fluorouridine in cancer cells through induction of uridine phosphorylase
Mol. Pharmacol.
76
854-860
2009
Homo sapiens
brenda
Roosild, T.P.; Castronovo, S.; Villoso, A.; Ziemba, A.; Pizzorno, G.
A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity
J. Struct. Biol.
176
229-237
2011
Homo sapiens (O95045), Homo sapiens
brenda
Roosild, T.; Castronovo, S.
Active site conformational dynamics in human uridine phosphorylase 1
PLoS ONE
5
e12741
2010
Homo sapiens (Q16831), Homo sapiens
brenda
Renck, D.; Machado, P.; Souto, A.A.; Rosado, L.A.; Erig, T.; Campos, M.M.; Farias, C.B.; Roesler, R.; Timmers, L.F.; de Souza, O.N.; Santos, D.S.; Basso, L.A.
Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity
J. Med. Chem.
56
8892-8902
2013
Homo sapiens (Q16831), Homo sapiens
brenda
Wang, J.; Xu, S.; Lv, W.; Shi, F.; Mei, S.; Shan, A.; Xu, J.; Yang, Y.
Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma
Cancer Med.
9
5940-5947
2020
Homo sapiens (Q16831), Homo sapiens
brenda
Guan, Y.; Bhandari, A.; Zhang, X.; Wang, O.
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines
J. Cell. Mol. Med.
23
7438-7448
2019
Homo sapiens (Q16831)
brenda